Amedeo Smart

Free Medical Literature Service



Liver Diseases

  Free Subscription


2 Am J Gastroenterol
6 Biochem Biophys Res Commun
3 BMC Cancer
3 BMC Gastroenterol
1 Cancer
2 Dig Dis Sci
1 Eur J Pediatr
1 Gastroenterology
15 Hepatology
1 J Gastroenterol Hepatol
2 N Engl J Med
2 PLoS One
1 Radiology
1 Transplant Proc

    Am J Gastroenterol

  1. LONG A, Magrath M, Mihalopoulos M, Rule JA, et al
    Changes in Epidemiology of Acetaminophen Overdoses in an Urban County Hospital After 20 Years.
    Am J Gastroenterol. 2022;117:1324-1328.
    >> Share

  2. YAMASHITA M, Kugiyama T, Takei D, Hara Y, et al
    An Unexpected Case of Fishbone-Induced Liver Abscess Through the Gallbladder.
    Am J Gastroenterol. 2022 Apr 13. pii: 00000434-990000000-00328.
    >> Share

    Biochem Biophys Res Commun

  3. CHEN Y, Zhang X
    TRABID targets DDB2 for deubiquitination to promote proliferation of hepatocellular carcinoma cells.
    Biochem Biophys Res Commun. 2022;625:23-30.
    >> Share

  4. MORI J, Sawada T, Baba T, Hayakawa A, et al
    Identification of cell cycle-associated and -unassociated regulators for expression of a hepatocellular carcinoma oncogene cyclin-dependent kinase inhibitor 3.
    Biochem Biophys Res Commun. 2022;625:46-52.
    >> Share

  5. LI L, Li S, Wang H, Li L, et al
    GSG2 promotes tumor growth through regulating cell proliferation in hepatocellular carcinoma.
    Biochem Biophys Res Commun. 2022;625:109-115.
    >> Share

  6. ZHANG W, Xue H, Zhou C, Zheng Z, et al
    7-aminocephalosporanic acid, a novel HSP90beta inhibitor, attenuates HFD-induced hepatic steatosis.
    Biochem Biophys Res Commun. 2022;622:184-191.
    >> Share

  7. ZHONG F, Chen T, Li B
    Combinatorial transcriptional regulation of HEB/ZEB1/ASCL1 and MYBL2 on Ras/ErbB signaling.
    Biochem Biophys Res Commun. 2022;622:170-176.
    >> Share

  8. XU M, Wu X, Liu Z, Ding Y, et al
    A novel mouse model of diabetes, atherosclerosis and fatty liver disease using an AAV8-PCSK9-D377Y injection and dietary manipulation in db/db mice.
    Biochem Biophys Res Commun. 2022;622:163-169.
    >> Share

    BMC Cancer

  9. CHEN B, Yang Z, Lang Z, Tao Q, et al
    M6A-related lncRNAs predict clinical outcome and regulate the tumor immune microenvironment in hepatocellular carcinoma.
    BMC Cancer. 2022;22:867.
    >> Share

  10. LI H, Xu L, Yi P, Li L, et al
    High-throughput circular RNA sequencing reveals the profiles of circular RNA in non-cirrhotic hepatocellular carcinoma.
    BMC Cancer. 2022;22:857.
    >> Share

  11. SONG M, Liu T, Liu H, Zhang Q, et al
    Association between metabolic syndrome, C-reactive protein, and the risk of primary liver cancer: a large prospective study.
    BMC Cancer. 2022;22:853.
    >> Share

    BMC Gastroenterol

  12. RAHIMPOUR Z, Hoseini R, Behpour N
    Alterations of liver enzymes and lipid profile in response to exhaustive eccentric exercise: vitamin D supplementation trial in overweight females with non-alcoholic fatty liver disease.
    BMC Gastroenterol. 2022;22:372.
    >> Share

  13. ZHAO M, Wang Y, Zhang Y, Li X, et al
    The upregulation of stromal antigen 3 expression suppresses the phenotypic hallmarks of hepatocellular carcinoma through the Smad3-CDK4/CDK6-cyclin D1 and CXCR4/RhoA pathways.
    BMC Gastroenterol. 2022;22:378.
    >> Share

  14. LIU X, Taylor SA, Celaj S, Levitsky J, et al
    Expression of unfolded protein response genes in post-transplantation liver biopsies.
    BMC Gastroenterol. 2022;22:380.
    >> Share


  15. JALAL PK
    Hepatitis C infection and advanced hepatocellular carcinoma-To treat or not to treat?
    Cancer. 2022 Aug 9. doi: 10.1002/cncr.34408.
    >> Share

    Dig Dis Sci

  16. CHAPIN SE, Goldberg DS, Kaplan DE, Mahmud N, et al
    External Validation of the FIPS Score for Post-TIPS Mortality in a National Veterans Affairs Cohort.
    Dig Dis Sci. 2022;67:4581-4589.
    >> Share

  17. FERREIRA RD, John BV
    Viral Vector Vaccines Are Victorious Against COVID-19 in Patients with Cirrhosis.
    Dig Dis Sci. 2022 Aug 10. pii: 10.1007/s10620-022-07644.
    >> Share

    Eur J Pediatr

  18. JULIAN V, Bergsten P, Ennequin G, Forslund A, et al
    Association between alanine aminotransferase as surrogate of fatty liver disease and physical activity and sedentary time in adolescents with obesity.
    Eur J Pediatr. 2022;181:3119-3129.
    >> Share


  19. LO GH
    The beauty and sorrow of using PPI in patients with cirrhosis.
    Gastroenterology. 2022 Aug 3. pii: S0016-5085(22)00892.
    >> Share


  20. LIU X, Wang K, Wang L, Kong L, et al
    Hepatocyte Ltb4r1 promotes NAFLD development in obesity.
    Hepatology. 2022 Aug 5. doi: 10.1002/hep.32708.
    >> Share

  21. RODRIGUEZ TC, Kwan S, Smith JL, Dadafarin S, et al
    Multi-omics characterization of mouse hepatoblastoma identifies novel YAP1 target genes.
    Hepatology. 2022 Aug 6. doi: 10.1002/hep.32713.
    >> Share

  22. WU Y, Hao X, Wei H, Sun R, et al
    TIGIT blockade elicits potent anti-tumor immunity in naturally occurring hepatitis B virus-related hepatocellular carcinoma in mice.
    Hepatology. 2022 Aug 8. doi: 10.1002/hep.32715.
    >> Share

  23. NING C, Zhang XM, Sang XT, Zhao HT, et al
    Letter to the editor: Cautious interpretation of the compensation of insulin-mTORC1 activation to promote liver regeneration in the absence of hepatocyte beta-catenin.
    Hepatology. 2022 Aug 2. doi: 10.1002/hep.32695.
    >> Share

  24. ALVA-RUIZ R, Ahn JC, Udompap P, Diaz LA, et al
    Hepatology highlights.
    Hepatology. 2022;76:539-540.
    >> Share

  25. LIU T, Wang Q, Zhou L, Zhang P, et al
    Intrahepatic paracrine signaling by CLCF1 ameliorates diet-induced NASH in mice.
    Hepatology. 2022 Aug 11. doi: 10.1002/hep.32719.
    >> Share

  26. GOUON-EVANS V, Fiorotto R
    Fibroblasts to hepatocytes: a non-stop flight into cell therapy for liver diseases?
    Hepatology. 2022 Aug 11. doi: 10.1002/hep.32725.
    >> Share

  27. LIN Y, Dong MQ, Liu ZM, Xu M, et al
    A strategy of vascular-targeted therapy for liver fibrosis.
    Hepatology. 2022;76:660-675.
    >> Share

  28. CALCAGNO DM, Chu A, Gaul S, Taghdiri N, et al
    NOD-like receptor protein 3 activation causes spontaneous inflammation and fibrosis that mimics human NASH.
    Hepatology. 2022;76:727-741.
    >> Share

  29. ZHENG M, Allington G, Vilarinho S
    Genomic medicine for liver disease.
    Hepatology. 2022;76:860-868.
    >> Share

    Will inhibition of cellular crosstalk resolve liver fibrosis?
    Hepatology. 2022;76:558-560.
    >> Share

  31. ZABALETA N, Torella L, Weber ND, Gonzalez-Aseguinolaza G, et al
    mRNA and gene editing: Late breaking therapies in liver diseases.
    Hepatology. 2022;76:869-887.
    >> Share

  32. BASS LM, Ye W, Hawthorne K, Leung DH, et al
    The Risk of Variceal Hemorrhage and Pre-Transplant Mortality in Children with Biliary Atresia.
    Hepatology. 2022 Mar 10. doi: 10.1002/hep.32451.
    >> Share

  33. CULLARO G, Verna EC, McCulloch CE, Lai JC, et al
    Improving the Model for End-Stage Liver Disease with sodium by incorporating kidney dysfunction types.
    Hepatology. 2022;76:689-699.
    >> Share

  34. JENSEN DM, Rzepczynski A, Jensen EE, Reau N, et al
    The American Association for the Study of Liver Diseases: A history of the first 10 years and its presidents.
    Hepatology. 2022;76:854-859.
    >> Share

    J Gastroenterol Hepatol

  35. KAWAHARA A, Kanno K, Yonezawa S, Otani Y, et al
    Depletion of hepatic stellate cells inhibits hepatic steatosis in mice.
    J Gastroenterol Hepatol. 2022 Aug 6. doi: 10.1111/jgh.15974.
    >> Share

    N Engl J Med

  36. VERWEIJ N, Haas ME, Nielsen JB, Sosina OA, et al
    Germline Mutations in CIDEB and Protection against Liver Disease.
    N Engl J Med. 2022;387:332-344.
    >> Share

  37. STRNAD P, Mandorfer M, Choudhury G, Griffiths W, et al
    Fazirsiran for Liver Disease Associated with Alpha1-Antitrypsin Deficiency.
    N Engl J Med. 2022;387:514-524.
    >> Share

    PLoS One

  38. ABDULMALEK S, Mostafa N, Gomaa M, El-Kersh M, et al
    Bee venom-loaded EGFR-targeting peptide-coupled chitosan nanoparticles for effective therapy of hepatocellular carcinoma by inhibiting EGFR-mediated MEK/ERK pathway.
    PLoS One. 2022;17:e0272776.
    >> Share

  39. CULP WTN, Johnson EG, Giuffrida MA, Rebhun RB, et al
    Evaluation of the use of a novel bioabsorbable polymer drug-eluting microsphere for transarterial embolization of hepatocellular neoplasia in dogs.
    PLoS One. 2022;17:e0269941.
    >> Share


  40. CHOI SJ, Lee SS, Jung KH, Lee JB, et al
    Noncirrhotic Portal Hypertension after Trastuzumab Emtansine in HER2-positive Breast Cancer as Determined by Deep Learning-measured Spleen Volume at CT.
    Radiology. 2022 Aug 9:220536. doi: 10.1148/radiol.220536.
    >> Share

    Transplant Proc

  41. OKUMURA K, Sogawa H, Samson D, Butler J, et al
    Improving Liver Transplant Outcomes for Hepatitis C Virus Hepatocellular Carcinoma in the Direct-Acting Antiviral Therapy Era.
    Transplant Proc. 2022 Aug 4. pii: S0041-1345(22)00445.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016